Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
1 The older STEP 1 trial studied the 2.4 mg dose on its own in 1,961 adults without diabetes, and found an average weight loss of 14.9% over 68 weeks, compared with 2.4% on placebo
/assets/production/practices/bb098bde1976b73281d3b963c3dfa64815de4cfc/images/2780379.jpeg)
Uses Elective use in adult patients with a BMI 25 for weight loss and metabolic optimization
Tirzepatide has not been extensively linked to liver damage in clinical studies, but as with any medication that affects metabolic processes, its advisable to monitor liver function, especially in patients with pre-existing liver conditions
Companies like Eli Lilly must continue to monitor product stability over time through a process called ongoing stability testing
US$ 24.02
US$ 23.42
US$ 29.70
US$ 25.59
US$ 28.53
